Stock PK5 BASILEA PHARMACEUTICA AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Basilea Pharmaceutica AG Xetra

Equities

PK5

CH0011432447

Chart calendar Basilea Pharmaceutica AG

2733c3eeefd8ce7b5d.MYhxhjhIk8rXGMaoVcv6i4zHZyP7IhWOYtN--OdSZyM.ScU4v00ayqacV6jqZ6GN8fqgDWSSSFfIG7cowKINI2VX2RirChnwoJNglw~235c16663db4a79b8ed097c4987ad1d8

Upcoming events on Basilea Pharmaceutica AG

13/08/2024 Q2 2024 Earnings Release
19/09/2024 Pareto Securities Healthcare Conference
18/02/2025 Q4 2024 Earnings Release (Projected)
19/08/2025 Q2 2025 Earnings Release (Projected)
17/02/2026 Q4 2025 Earnings Release (Projected)
18/08/2026 Q2 2026 Earnings Release (Projected)

Past events on Basilea Pharmaceutica AG

27/04/2024 European Society of Clinical Microbiology and Infectious Diseases Global Meeting
24/04/2024 05:30 pm Annual General Meeting
11/04/2024 Capital Markets Day
21/03/2024 Kepler Cheuvreux Swiss Seminar
13/02/2024 08:30 pm Q4 2023 Earnings Call
13/02/2024 11:45 am Q4 2023 Earnings Release
10/01/2024 Baader Helvea Swiss Equities Conference
08/01/2024 Edison Healthcare Week
14/11/2023 Jefferies London Healthcare Conference
13/11/2023 08:30 pm Business Update Call
11/10/2023 IDWeek Conference - Abstract No:1946
11/10/2023 IDWeek Conference - Abstract No:2162
11/10/2023 IDWeek Conference - Abstract No:2561
11/10/2023 IDWeek Conference - Abstract No:2531
11/10/2023 IDWeek Conference - Abstract No:2530
11/10/2023 IDWeek Conference - Abstract No:2532
11/10/2023 IDWeek Conference - Abstract No:2173
11/10/2023 IDWeek Conference - Abstract No:2785
25/09/2023 HBM Biopharma Summit
14/09/2023 Pareto Securities' Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CHF		Released
Forecast
Spread 		134
133
0.77%		128
131
-2.39%		148
145
2.41%		148
122
21.38%		158
156
0.97%
182

EBITDA
Million CHF		Released
Forecast
Spread 		-15,6
-23,5
33.65%		-22,1
-21,5
-2.73%		1,93
-13,4
114.36%		19,6
-4,21
566.99%		20,8
15,8
31.62%
33,8

EBIT
Million CHF		Released
Forecast
Spread 		-17,2
-26,4
34.82%		-8,22
-11,2
26.47%		1,20
-13,0
109.26%		18,5
-4,80
485.36%		19,2
14,8
29.78%
31,8

Earnings before Tax (EBT)
Million CHF		Released
Forecast
Spread 		-22,4
-31,3
28.5%		-14,7
-16,4
10.59%		-6,80
-22,2
69.37%		12,1
-13,9
187.12%		10,5
5,36
95.31%
27,6

Net income
Million CHF		Released
Forecast
Spread 		-22,4
-32,1
30.12%		-14,7
-16,4
10.35%		-6,80
-20,7
67.07%		12,1
-13,9
187.38%		10,5
5,35
96.21%
26,3

EPS
CHF		Released
Forecast
Spread 		-2,08
-2,88
27.71%		-1,43
-1,52
6.13%		-0,58
-1,83
68.22%		1,02
-1,35
175.67%		0,86
0,43
101.28%
2,12

Announcement Date18/02/2016/02/2115/02/2214/02/2313/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 Q2 2023 S1 2023 S2 2024 Q2 2024 S1 2024 Q4 2024 S2
Net sales
Million CHF		Released
Forecast
Spread 		71,2
70,2
1.36%		69,3
63,0
9.96%		58,3
60,2
-3.07%		54,2
58,7
-7.67%		93,9


58,6
42,4
38.32%		89,2
56,2
58.64%
83,8

84,9
64,7
31.15%		72,7
72,0
0.95%
80,7


85,9


98,7


95,3

EBITDA
Million CHF		Released
Forecast
Spread


























-16,9
-22,0
23.32%



12,9





18,0

EBIT
Million CHF		Released
Forecast
Spread 		-4,00
-10,3
61%		12,8
-14,9
186.04%		-21,0
-25,6
17.83%		-15,4
-13,5
-14.5%		16,6
3,60
361.11%		-9,04
-15,7
42.41%		27,5
-7,85
450.84%


36,9
13,1
182.4%		-17,7
-21,7
18.28%
12,9


15,0


18,0


15,0

Earnings before Tax (EBT)
Million CHF		Released
Forecast
Spread 		-6,97
-13,6
48.77%		9,97
-14,2
170.07%		-24,6
-29,9
17.59%		-19,9
-10,8
-84.05%		13,1
0,80
1535.25%		-12,2
-18,3
33.22%		24,3
-9,80
348.19%


31,9
10,3
209.39%		-21,4
-26,3
18.61%
10,7


12,4


18,5


14,6

Net income
Million CHF		Released
Forecast
Spread 		-7,00
-13,6
48.55%		9,90
-14,4
168.92%		-24,7
-29,9
17.52%		-19,9
-10,8
-84.26%		13,1
0,80
1537.5%		-12,2
-18,3
33.28%		24,4
-9,80
348.53%


31,8
8,73
264.12%		-21,3
-26,0
18.15%
9,34


11,7


16,1


13,4

EPS
CHF		Released
Forecast
Spread 		-0,64
-1,23
47.83%		0,91
-1,29
170.82%		-2,34
-2,62
10.69%		-1,84
-1,01
-82.18%		1,26
0,07
1700%		-1,03
-1,55
33.55%		2,05
-0,82
350%


2,42
0,73
231.51%		-1,56
-2,05
23.72%
0,71


0,94


1,23


1,05

Announcement Date18/02/2011/08/2016/02/2117/08/2115/02/2216/08/2214/02/23-15/08/2313/02/24----

Upcoming sector events for Basilea Pharmaceutica AG

15/07/2024 11:15 am ADDLIFE AB: Q2 2024 Earnings Release
22/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release
24/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
24/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
24/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
25/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 10:30 am BACHEM HOLDING AG: Q2 2024 Earnings Release
26/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 10:30 am BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Basilea Pharmaceutica AG

07/06/2024 12:27 pm POLARIS GROUP: May 2024 Sales and Revenue Release
30/05/2024 01:31 am IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 04:30 pm CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 10:30 am EVOTEC SE: Q1 2024 Earnings Release
22/05/2024 02:44 am ALVOTECH: Q1 2024 Earnings Release
21/05/2024 04:30 pm EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 11:30 am BIOARCTIC AB: Q1 2024 Earnings Release
16/05/2024 01:35 am CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. BSLN Stock
  4. PK5 Stock
  5. Calendar Basilea Pharmaceutica AG